Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Participants needed: 10
Trial details
Age: 22-60Biological sex: AllType: InterventionalSponsor: Nanochon, Inc.Updated: Apr 22, 2026Locations: 2
Eligibility criteria

Male or female ≥22 years and ≤ 60 years of age [+3]

Any known systemic cartilage and/or bone disorder, such as, but not limited to,... [+15]

Status: Not yet recruiting

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Participants needed: 5
Trial details
Age: 22-60Biological sex: AllType: InterventionalSponsor: Nanochon, Inc.Updated: Apr 21, 2026Locations: 1
Eligibility criteria

Male or female ≥22 years and ≤ 60 years of age [+3]

Any known systemic cartilage and/or bone disorder, such as, but not limited to,... [+15]